0001193125-21-102534.txt : 20210331 0001193125-21-102534.hdr.sgml : 20210331 20210331172003 ACCESSION NUMBER: 0001193125-21-102534 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210331 DATE AS OF CHANGE: 20210331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Liminal BioSciences Inc. CENTRAL INDEX KEY: 0001351172 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39131 FILM NUMBER: 21794674 BUSINESS ADDRESS: STREET 1: 440 BOULEVARD ARMAND STREET 2: FRAPPIER #300 CITY: LAVAL STATE: A8 ZIP: H7V 4B4 BUSINESS PHONE: 450-781-0115 MAIL ADDRESS: STREET 1: 440 BOULEVARD ARMAND STREET 2: FRAPPIER #300 CITY: LAVAL STATE: A8 ZIP: H7V 4B4 FORMER COMPANY: FORMER CONFORMED NAME: ProMetic Life Sciences Inc DATE OF NAME CHANGE: 20060126 6-K 1 d116611d6k.htm 6-K 6-K

 

 

UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of March 2021

Commission File Number: 001-39131

 

 

LIMINAL BIOSCIENCES INC.

(Translation of registrant’s name into English)

 

 

440 Armand-Frappier Boulevard, Suite 300

Laval, Québec

H7V 4B4

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒    Form 20-F              ☐    Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On March 29, 2021, Liminal BioSciences Inc. filed a Notice of Meeting and Record Date in preparation for its annual and special meeting of shareholders. Shareholders can please visit the investor website to access a copy of the annual report here: https://liminalbiosciences.com/resources/latest-content.

EXHIBIT LIST

 

Exhibit

   

Description

99.1    Notice of Meeting and Record Date

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   Liminal BioSciences Inc.
Date: March 31, 2021    By:   

/s/ Bruce Pritchard

      Name    Bruce Pritchard
      Title:    Chief Executive Officer
 EX-99.1 2 d116611dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

March 29, 2021      1500 Robert-Bourassa Blvd., 7th Floor
     Montreal QC, H3A 3S8
     www.computershare.com

To: All Canadian Securities Regulatory Authorities

Subject: LIMINAL BIOSCIENCES INC

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

 

Meeting Type :    Annual General and Special Meeting   
Record Date for Notice of Meeting :    April 23, 2021   
Record Date for Voting (if applicable) :    April 23, 2021   
Beneficial Ownership Determination Date :    April 23, 2021   
Meeting Date :    June 04, 2021   
Meeting Location (if available) :    Virtual Meeting   
Issuer sending proxy related materials directly to NOBO:    No   
Issuer paying for delivery to OBO:    Yes   

Notice and Access (NAA) Requirements:

 

NAA for Beneficial Holders

    Yes   

Beneficial Holders Stratification Criteria:

    Not Applicable   

NAA for Registered Holders

    Yes   

Registered Holders Stratification Criteria:

    Not Applicable   

Voting Security Details:

 

Description    CUSIP Number    ISIN
COMMON SHARES    53272L103    CA53272L1031

Sincerely,

Computershare

Agent for LIMINAL BIOSCIENCES INC

GRAPHIC 3 g116611g0401022738914.jpg GRAPHIC begin 644 g116611g0401022738914.jpg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end